✦ LIBER ✦

Supplement 1 || In Vivo Transgenic Bioassays and Assessment of the Carcinogenic Potential of Pharmaceuticals

✍ Scribed by Joseph F. Contrera and Joseph J. DeGeorge

Book ID: 124291109
Publisher: Environmental Health Information Service
Year: 1998
Tongue: English
Weight: 436 KB
Volume: 106
Category: Article
ISSN: 0091-6765
DOI: 10.2307/3433913

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Supplement 2 || Evaluation and Validatio

Supplement 2 || Evaluation and Validation Issues in the Development of Transgenic Mouse Carcinogenicity Bioassays

✍ Raymond W. Tennant 📂 Article 📅 1998 🏛 Environmental Health Information Service 🌐 English ⚖ 751 KB

The in Vivo Rodent Test Systems for Asse

The in Vivo Rodent Test Systems for Assessment of Carcinogenic Potential

✍ Jan-Willem van der Laan; Per Spindler 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Emerging technologies—the use of transge

Emerging technologies—the use of transgenic mice for assessing mutagenic potential in vivo

✍ R. A. Leboeuf 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Evaluation of the in vivo genotoxic pote

Evaluation of the in vivo genotoxic potential of 3 carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay

✍ F. Locher; R. Ahiabor; B. Blanco; F. Mantovani; M. Robinson; G. Sreenan; F. Städ 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Predicting the carcinogenic potential of

Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices

✍ Joseph F Contrera; Edwin J Matthews; R Daniel Benz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 389 KB

Hemizygous Tg.AC transgenic mouse as a p

Hemizygous Tg.AC transgenic mouse as a potential alternative to the two-year mouse carcinogenicity bioassay: evaluation of husbandry and housing factors

✍ Henry E. Holden; Raymond E. Stoll; Judson W. Spalding; Raymond W. Tennant 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

The dermal Tg.AC transgenic mouse model has been proposed as a potential alternative to the conventional (e.g. oral, dermal, parenteral, inhalation, etc.) 2-year rodent bioassay for detecting chemical carcinogenicity. The present study was designed to address a number of technical aspects of this mo